Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-02-11 @ 12:06 PM
Study NCT ID:
NCT05757466
Status:
RECRUITING
Last Update Posted:
2023-12-19
First Post:
2023-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma
Sponsor:
St. Petersburg State Pavlov Medical University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hodgkin Lymphoma | View |